Advertisement

Tropical Diseases

  • Jan von Overbeck
  • Fajah S. Peshi

Abstract

The problem of life insurance in tropical or subtropical climates can be studied from two angles: first as it applies to inhabitants of temperate zones visiting, traveling or residing in the tropics; secondly as it applies to indigenous populations. The latter, in addition to being subject to the diseases peculiar to their race, are exposed to hazards of climatic conditions and tropical disease, which may vary in severity from area to area.

Keywords

Endemic Area Visceral Leishmaniasis Dengue Virus Dengue Fever Life Insurance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blair JE. Evaluation of fever in the international traveler. Unwanted ‘souvenir’ can have many causes. Postgrad Med 2004; 116(1): 13–20.CrossRefGoogle Scholar
  2. 2.
    Spira AM. Assessment of travellers who return home ill. Lancet 2003 26; 361(9367): 1459–69.CrossRefGoogle Scholar
  3. 3.
    Newman RD et al. Malaria-related deaths among US travelers, 1963–2001. Ann Intern Med. 2004; 141(7): 547–55.CrossRefGoogle Scholar
  4. 4.
    Kiszewski AE, Teklehaimanot A. A review of the clinical and epidemiologic burdens of epidemic malaria. Am J Trop Med Hyg 2004; 71(2 Suppl): 128–35.Google Scholar
  5. 5.
    Re VL III, Gluckman SJ. Prevention of malaria in travelers. Am Fam Physician 2003; 68(3): 509–14.Google Scholar
  6. 6.
    Jones CO, Williams HA. The social burden of malaria: what are we measuring? Am J Trop Med Hyg 2004; 71(2 Suppl): 156–61.Google Scholar
  7. 7.
    Bedu-Addo G, Bates I. Causes of massive tropical splenomegaly in Ghana. Lancet 2002; 360(9331): 449–54.CrossRefGoogle Scholar
  8. 8.
    Welburn SC, Odiit M. Recent developments in human African trypanosomiasis. Curr Opin Infect Dis 2002; 15(5): 477–84.CrossRefGoogle Scholar
  9. 9.
    Kennedy PG. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004; 113 (4): 496–504.CrossRefGoogle Scholar
  10. 10.
    Fairlamb AH. Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol 2003; 19(11): 488–94.CrossRefGoogle Scholar
  11. 11.
    Burri C, Brun R. Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res 2003; 90(Suppl): S49–52.Google Scholar
  12. 12.
    Miles MA, Feliciangeli MD, de Arias AR. American trypanosomiasis (Chagas’ disease) and the role of molecular epidemiology in guiding control strategies. BMJ 2003; 326(7404): 1444–8.CrossRefGoogle Scholar
  13. 13.
    Higuchi M de L et al. Pathophysiology of the heart in Chagas’ disease: current status and new developments. Cardiovasc Res. 2003; 60(1): 96–107CrossRefGoogle Scholar
  14. 14.
    Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001 ; 1 (2): 92–100.CrossRefGoogle Scholar
  15. 15.
    Magill AJ. Epidemiology of the leishmaniases. Dermatol Clin 1995; 13(3): 505–23.Google Scholar
  16. 16.
    Grimaldi G Jr, Tesh RB. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 1993; 6(3): 230–50.Google Scholar
  17. 17.
    Guerin PJ et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2(8): 494–01.CrossRefGoogle Scholar
  18. 18.
    Tanyuksel M, Petri WA Jr. Laboratory diagnosis of amebiasis. Clin Microbiol Rev 2003; 16(4): 713–29.CrossRefGoogle Scholar
  19. 19.
    Haque R et al. Amebiasis. N Engl J Med 2003; 348(16): 1565–73.CrossRefGoogle Scholar
  20. 20.
    Thompson RC. Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol 2000; 30(12–13): 1259–67.Google Scholar
  21. 21.
    Jelinek T. Dengue fever in international travelers. Clin Infect Dis 2000; 31(1): 144–7.CrossRefGoogle Scholar
  22. 22.
    Rigau-Perez JG et al. Dengue and dengue haemor-rhagic fever. Lancet 1998; 352(9132): 971–7.CrossRefGoogle Scholar
  23. 23.
    Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11(3): 480–96.Google Scholar
  24. 24.
    Monath TP. Yellow fever: an update. Lancet Infect Dis 2001; 1(1): 11–20.CrossRefGoogle Scholar
  25. 25.
    Britton WJ, Lockwood DN. Leprosy. Lancet 2004; 363(9416): 1209–19.CrossRefGoogle Scholar
  26. 26.
    Kammerer WS, Schantz PM. Echinococcal disease. Infect Dis Clin North Am 1993; 7(3): 605–18.Google Scholar
  27. 27.
    Garcia HH et al. Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 2003; 362(9383): 547–56.CrossRefGoogle Scholar
  28. 28.
    Vennervald BJ, Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 2004; 17(5): 439–47.CrossRefGoogle Scholar
  29. 29.
    Ross AG et al. Schistosomiasis. N Engl J Med 2002; 346(16): 1212–20.CrossRefGoogle Scholar
  30. 30.
    Mostafa MH, Sheweita SA, O’Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999; 12(1): 97–111.Google Scholar
  31. 31.
    Hotez PJ et al. Hookworm infection. N Engl J Med 2004; 351(8): 799–807.CrossRefGoogle Scholar
  32. 32.
    Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 2003; 16(2): 265–72.CrossRefGoogle Scholar
  33. 33.
    Melrose WD. Lymphatic filariasis: new insights into an old disease. Int J Parasitol 2002; 32(8): 947–60.CrossRefGoogle Scholar
  34. 34.
    Michael E et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis 2004; 4(4): 223–34.CrossRefGoogle Scholar
  35. 35.
    Leggat PA, Melrose W, Durrheim DN. Could it be lymphatic filariasis? J Travel Med 2004; 11(1): 56–60.CrossRefGoogle Scholar
  36. 36.
    Boatin BA et al. Diagnostics in onchocerciasis: future challenges. Ann Trop Med Parasitol 1998; 92(Suppll): S41–5CrossRefGoogle Scholar
  37. 37.
    Burnham G. Onchocerciasis. Lancet 1998; 351(9112): 1341–6.CrossRefGoogle Scholar
  38. 38.
    Cheung SS, Sleivert GG. Multiple triggers for hyperthermic fatigue and exhaustion. Exerc Sport Sci Rev 2004; 32(3): 100–6.CrossRefGoogle Scholar
  39. 39.
    Lugo-Amador NM, Rothenhaus T, Moyer P. Heat-related illness. Emerg Med Clin North Am 2004; 22(2): 315–27.CrossRefGoogle Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Limited 2006

Authors and Affiliations

  • Jan von Overbeck
  • Fajah S. Peshi

There are no affiliations available

Personalised recommendations